Toshiyuki Marumo

发表

Serum S100B, brain edema, and hematoma formation in a rat model of collagenase-induced hemorrhagic stroke

S. Yoshida, Hiromi Shibuta, T. Omura, 2009, Brain Research Bulletin.

The inhibitor of 20‐HETE synthesis, TS‐011, improves cerebral microcirculatory autoregulation impaired by middle cerebral artery occlusion in mice

J. Nabekura, K. Eto, H. Wake, 2010, British journal of pharmacology.

Serum S100B indicates successful combination treatment with recombinant tissue plasminogen activator and MK-801 in a rat model of embolic stroke

S. Yoshida, T. Omura, Yu Tanaka, 2007, Brain Research.

Quantitative assessments of cerebral vascular damage with a silicon rubber casting method in photochemically-induced thrombotic stroke rat models.

S. Yoshida, T. Omura, Yu Tanaka, 2007, Life sciences.

Increase of 20-HETE Synthase after Brain Ischemia in Rats Revealed by PET Study with 11C-Labeled 20-HETE Synthase-Specific Inhibitor

H. Onoe, Yasuyoshi Watanabe, S. Chaki, 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Serum S100B indicates brain edema formation and predicts long-term neurological outcomes in rat transient middle cerebral artery occlusion model

S. Yoshida, T. Omura, Chie Koizumi, 2007, Brain Research.

Serum S100B is a useful surrogate marker for long-term outcomes in photochemically-induced thrombotic stroke rat models.

S. Yoshida, T. Omura, Chie Koizumi, 2007, Life sciences.

Early increases in serum S100B are associated with cerebral hemorrhage in a rat model of focal cerebral ischemia

S. Yoshida, T. Omura, Yu Tanaka, 2008, Brain Research.

JPET #218651 1 Neurophysiological and Antipsychotic Profiles of TASP0433864, a Novel Positive Allosteric Modulator of Metabotropic Glutamate 2 Receptor

S. Chaki, H. Hikichi, J. Karasawa, 2014 .

Discovery of MGS0274, an ester prodrug of a metabotropic glutamate receptor 2/3 agonist with improved oral bioavailability.

S. Chaki, H. Hikichi, N. Miyakoshi, 2020, European journal of medicinal chemistry.

A Novel Potent and Selective Histamine H3 Receptor Antagonist Enerisant: In Vitro Profiles, In Vivo Receptor Occupancy, and Wake-Promoting and Procognitive Effects in Rodents

S. Chaki, Emi Tatsuda, Toshio Nakamura, 2020, The Journal of Pharmacology and Experimental Therapeutics.

Relationship between cerebrospinal and peripheral S100B levels after focal cerebral ischemia in rats

S. Yoshida, T. Omura, Yu Tanaka, 2008, Neuroscience Letters.

Antipsychotic profiles of TASP0443294, a novel and orally active positive allosteric modulator of metabotropic glutamate 2 receptor.

S. Chaki, H. Hikichi, J. Karasawa, 2015, Journal of pharmacological sciences.

Neurophysiologic and Antipsychotic Profiles of TASP0433864, a Novel Positive Allosteric Modulator of Metabotropic Glutamate 2 Receptor

S. Chaki, H. Hikichi, J. Karasawa, 2014, The Journal of Pharmacology and Experimental Therapeutics.

Evaluation of the Safety, Tolerability, and Pharmacokinetic Profiles of TP0473292 (TS-161), A Prodrug of a Novel Orthosteric mGlu2/3 Receptor Antagonist TP0178894, in Healthy Subjects and Its Antidepressant-Like Effects in Rodents

Brian Marcy, C. Zarate, S. Chaki, 2021, The international journal of neuropsychopharmacology.